Medical Equipment

Transcatheter Embolization And Occlusion Devices Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

March 17, 2026March 17, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Transcatheter Embolization And Occlusion Devices Market From 2026 To 2030?

The transcatheter embolization and occlusion devices market size has experienced swift expansion in recent years. It is forecast to grow from $5.23 billion in 2025 to $5.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The market’s historical growth can be attributed to the broadening scope of interventional radiology procedures, the increasing prevalence of vascular disorders, enhanced availability of catheter-based therapies, wider adoption of minimally invasive treatments, and improvements in imaging-guided intervention techniques.

The transcatheter embolization and occlusion devices market size is projected to experience significant expansion in the coming years. It is set to reach $8.33 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This anticipated growth throughout the forecast period is fueled by factors such as the increasing need for targeted embolization treatments, the rising integration of advanced embolic substances, the broadening scope of oncology and neurointerventional procedures, an intensifying focus on precision medicine, and escalating investments in interventional healthcare infrastructure. Prominent trends for the forecast period include the increasing uptake of minimally invasive embolization techniques, a growing demand for advanced liquid embolic agents, the expanding application of detachable and coated coils, the proliferation of image-guided interventional methods, and a heightened emphasis on precise occlusion technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp

What Drivers Are Influencing The Transcatheter Embolization And Occlusion Devices Market?

The escalating demand for minimally invasive surgical techniques is projected to propel the expansion of the transcatheter embolization and occlusion devices market. Minimally invasive surgeries involve utilizing small incisions or robotic-assisted instruments to access internal structures while minimizing tissue harm, leading to reduced trauma, expedited recovery times, less postoperative discomfort, and a diminished risk of complications. The increasing favor for these procedures is fueled by advancements in surgical technology, heightened patient awareness of less-invasive choices, and superior clinical outcomes. Transcatheter embolization and occlusion devices facilitate such minimally invasive interventions by enabling targeted, catheter-based treatment with high precision and minimal disruption to adjacent tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology corporation, full-year 2024 worldwide da Vinci procedures increased by approximately 17% compared with 2023. The company expects worldwide da Vinci procedures to grow by approximately 13% to 16% in 2025 compared with 2024. Consequently, the growing acceptance of minimally invasive techniques is a significant factor driving the transcatheter embolization and occlusion devices market.

Which Segments Are Included In The Analysis Of The Transcatheter Embolization And Occlusion Devices Market?

The transcatheter embolization and occlusion devices market covered in this report is segmented –

1) By Type: Coil, Non-Coil

2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users

Subsegments:

1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil

2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles

Which Trends Are Impacting The Growth Of The Transcatheter Embolization And Occlusion Devices Market?

Leading companies in the transcatheter embolization and occlusion devices market are focusing on developing advanced solutions, such as liquid embolic systems, to address the increasing demand for minimally invasive vascular interventions and effective management of arterial bleeding. A liquid embolic system is a non-adhesive, polymer-based embolization technology delivered through a microcatheter, solidifying upon contact with blood. This process enables controlled occlusion of abnormal or damaged vessels while providing deeper penetration and greater precision than traditional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, initiated clinical evaluation of its Onyx Liquid Embolic System (LES) through an IDE study, aimed at embolization of arterial hemorrhage in the peripheral vasculature. This innovative system employs an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and mixed with tantalum powder for radiopacity, allowing physicians to visualize and control the delivery in real time. It forms a cohesive embolus as the solvent diffuses, facilitating targeted vessel occlusion with a reduced risk of catheter entrapment and improved safety in complex anatomies. Designed for application in active peripheral arterial bleeding, the system enhances precision, supports minimally invasive treatment workflows, and expands therapeutic options for interventional specialists.

Which Key Industry Participants Are Active In The Transcatheter Embolization And Occlusion Devices Market?

Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular

Read the full transcatheter embolization and occlusion devices market report here:

https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Transcatheter Embolization And Occlusion Devices Market?

North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transcatheter Embolization And Occlusion Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15944&type=smp

Browse Through More Reports Similar to the Global Transcatheter Embolization And Occlusion Devices Market 2026, By The Business Research Company

Tumor Embolization Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Neurovascular Embolization Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurovascular-embolization-devices-global-market-report

Vascular Embolization Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795